BofA Securities made an adjustment to the price target for Altria stock, bringing it down to $61 from the previous $65, while still maintaining a Buy rating on the shares. This change was announced by ...
The Food and Drug Administration’s approval of low-risk tobacco pouches is welcome, but why did it delay for more than four ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback